05.10.2016 • News

Nobel Prize in Chemistry 2016

The Nobel Prize in Chemistry for 2016 has been awarded jointly to Jean-Pierre...
The Nobel Prize in Chemistry for 2016 has been awarded jointly to Jean-Pierre Sauvage, Sir J. Fraser Stoddart, and Bernard L. Feringa

The Nobel Prize in Chemistry for 2016 has been awarded jointly to Jean-Pierre Sauvage, University of Strasbourg, France, Sir J. Fraser Stoddart, Northwestern University, Evanston, IL, USA, and Bernard L. Feringa, University of Groningen, The Netherlands, "for the design and synthesis of molecular machines".
The Nobel Laureates have developed the world's smallest machines by taking molecular systems out of the stalemate of equilibrium into energy-filled states in which their movements can be controlled. Molecular machines will probably be used in the development of, e.g., new materials, sensors, and energy storage systems.
In 1983, Jean-Pierre Sauvage linked two ring-shaped molecules together to form a chain, called a catenane. The two interlocked rings can move relative to each other. In 1991, Fraser Stoddart developed a rotaxane. He demonstrated that a molecular ring on a thin molecular axle was able to move along the axle. Based on rotaxanes, he developed, for example, a molecular lift, a molecular muscle, and a molecule-based computer chip. In 1999, Bernard Feringa was the first person to develop a molecular motor and was, for example, able to design a nanocar.

Read more on www.chemistryviews.org.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.